An enzyme-linked immunosorbent assay (ELISA) was developed for the serodiagnosis of contagious equine metritis (CEM), a sexually transmitted disease caused by Taylorella equigenitalis. Antigen preparation was simple, and antigens derived from both classical and atypical forms of T. equigenitalis enabled detection of antibody responses elicted in horses experimentally exposed to either form of the bacterium. Sera serially obtained from these horses from 0 to 63 days postexposure were tested by the traditional complement fixation test (CFT) for CEM and with the ELISA, using both antigens separately. There was close agreement between CFT and ELISA methodologies during the postexposure time period used to detect CEM serodiagnostically in regulatory animal health testing programs. Unlike the CFT, which requires an overnight incubation step, the ELISAs are more convenient and can be completed in 3 hours.
Contagious equine metritis (CEM) is a sexually transmitted infectious infertility of equids caused by the bacterium Taylorella equigenitalis. 6, 7 Although endemic in many nations, CEM was eliminated from the US equine population in the early 1980s through stringent preventive regulatory diagnostic testing of both imported and domestic horses prior to use in breeding. 6, 7 Stallions may be persistently infected, but they rarely seroconvert; in contrast, mares rapidly but transiently seroconvert following infection and either fail to conceive or abort early. Because T. equigenitalis grows slowly and is difficult to consistently recover from both infected mares and infected stallions, serology in the mare is an essential tool for detecting, controlling, and preventing CEM epizootics in equine breeding populations. 6, 7 Traditionally, the complement fixation test (CFT) has been used in the United States for the serodiagnosis of CEM infections. 2, 5 The CFT requires, however, an overnight 4 C incubation, will not work reliably with previously frozen serum, and is frequently plagued by anticomplementary or spurious incomplete reactions that are difficult to interpret. 2, 5 In the first years after the recognition of CEM as a disease entity, a number of other serological approaches were investigated, including passive hemagglutination, gel immunodiffusion, plate agglutination, and complex early enzymelinked immunosorbent assay (ELISA) methodologies. 5 The simple and convenient ELISA described here can be completed in Ͻ3 hours, works equally well with fresh or previously frozen sera, and yields a well-defined differentiation between positive and negative serum samples.
Antigens for the ELISA were prepared from separate 6day-old Eugon a broth cultures of both classical T. equigenitalis and a recently discovered bacterium that very closely resembles T. equigenitalis but is still of uncertain taxonomic classification. 3 resuspended separately in ice cold water (10% w/v) for 4 hours and then sonicated for 8 minutes at 100 W. After centrifuging sonicates for 30 minutes at 10,000 ϫ g, the supernatants were held at Ϫ70 C for use as ELISA antigens (classical CEM Ag, CEM-related Ag). For the ELISA, all procedures were conducted using 50 l/well of each reagent. Dilutions of each antigen (1:2,550 v/v) in sodium bicarbonate buffer, pH 9.6, were placed into 96-well Immulon lb plates, c incubated at 4 C overnight, and then frozen (Ϫ70 C) until use. Plates were washed twice with 0.01 M phosphatebuffered saline with 0.05% Tween-20 (PBST), and 1:500 (v/ v) dilutions of equine serum were then incubated for 30 minutes at 37 C in 2 wells (1 coated with the classical CEM Ag and one coated with the CEM-related Ag).
Plates were subsequently washed 3 times in PBST, and biotinylated anti-equine IgG d was added to all wells and incubated for 30 minutes at 37 C. Plates were washed again and incubated for 15 minutes at 37 C with a streptavidinalkaline phosphatase enzyme conjugate. d After a final washing step, Blue-phos substrate e was added to all wells, and the resulting optical density was measured 15 minutes later at 590 nm (OD 590 ). Three mare sera were used as test controls, 1 from a CEM-free animal and 2 from mares exposed 67 days previously to either the classical or the recently discovered CEM-like organism. 3 Repeated tests (n ϭ 6) of serum from the uninfected mare yielded OD 590 values ( Ϯ X SD) of 0.07 Ϯ 0.04 and 0.05 Ϯ 0.03 in classical CEM Ag and CEM-related Ag wells respectively; this serum was also CFT negative at the 1:4 dilution. The other 2 sera were also CFT negative, but serum from the mare exposed to classical T. equigenitalis produced OD 590 values of 0.35 Ϯ 0.02 and 0.44 Ϯ 0.07 in classical CEM Ag and CEM-related Ag wells, respectively, and serum from the mare exposed to the newly discovered CEM-like isolate produced OD 590 values of 0.16 Ϯ 0.02 and 0.56 Ϯ 0.02 in classical CEM Ag and CEM-related Ag wells.
To further assess ELISA cutoff values, sera from 516 presumably CEM-free horses of United States origin were tested by ELISA. Using the classical and CEM-like T. equigenitalis antigens, the OD 590 of these sera were 0.05 Ϯ 0.02 and 0.03 Ϯ 0.02, respectively. Adding 3 standard deviations to each mean produced arbitrary cutoff values of 0.11 and 0.09. These cutoff values were examined in light of ELISA and CFT test results using serially collected serum samples from 6 experimentally infected mares (Table 1 ). Using those data (Table 1 ) and the cutoff values proposed, the CFT and both ELISA responses were in complete agreement for the first 35 days postexposure. Thereafter, both the ELISA and the CFT responses waned, although at different rates. Because both sources of ELISA antigen yielded complete agreement with the CFT during the critical early weeks postexposure, either antigen may be suitable for a CEM serologic screening test antigen.
For CEM regulatory animal health purposes, mares are serologically tested twice at least 7 days apart from 15 to 40 days postbreeding. 1, 4, 5, 7 The CFT and the ELISA results were in excellent agreement during that time period, and the proposed ELISA cutoff values will enable clear distinctions between positive and negative sera to be made. The speed, simplicity, and clarity of the CEM ELISA should be noted in considering the ELISA as a good replacement procedure for the CFT currently used for CEM serodiagnosis. An official methodological change should be made, however, only after the ELISA is applied to larger populations of Taylorella-seropositive and -seronegative mares and its performance found equal or superior to that of the current CFT procedure.
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